secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001104659-25-058523
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunome stockholders elect Barchas and Bienaimé as Class II directors; ratify Ernst & Young
--------------------------------------------------------------------------------

- Isaac Barchas elected with 46.3M votes for, 15.2M withheld; Jean-Jacques Bienaimé elected with 47.1M for, 14.4M withheld.
- Stockholders ratified Ernst & Young as auditor for FY2025 with 76.3M votes for, 16K against.
- Broker non-votes totaled 14.7M on both director proposals; none on auditor ratification.
- Meeting held June 10, 2025; 87,011,822 shares outstanding and entitled to vote as of April 21 record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465925058523/0001104659-25-058523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465925058523/tm2517681d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer